Loading...

Biofrontera Inc.

BFRI•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.08
$0.05(4.85%)
U.S. Market opens in NaNh NaNm

Biofrontera Inc. (BFRI) Stock Overview

Explore Biofrontera Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.6M
P/E Ratio-1.23
EPS (TTM)$-1.04
ROE-11.39%
Fundamental Analysis

AI Price Forecasts

1 Month$0.82
3 Months$0.49
1 Year Target$14.53

BFRI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biofrontera Inc. (BFRI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.23 and a market capitalization of 12.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.85%
5-Day Change
-0.92%
1-Month Change
33.17%
3-Month Change
8.00%
6-Month Change
-1.82%
Year-to-Date (YTD) Change
89.47%
1-Year Change
30.28%
3-Year Change
-90.56%
5-Year Change
-98.78%
All-Time (Max) Change
-98.78%

Contact Information

https://www.biofrontera.us.com
781 245 1325
120 Presidential Way, Woburn, MA, 01801

Company Facts

92 Employees
IPO DateOct 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions